Uniscreen

Uniscreen is an Indian multinational medical devices and healthcare company headquartered at IIT Madras Research Park in Chennai, Tamil Nadu. The company specializes in Continuous Glucose Monitoring (CGM) technology, developing affordable diabetic patch products for patients with diabetes. Its flagship product, the GlucoDetect™ Diabetic Patch, features a patented two-part modular design comprising a replaceable needle unit (lasting 14 days) and an integrated reader/display unit built using Electro-Thermo-Chromic Ink-based display technology — activated by micro-Volts compared to the high voltage required by LED displays. This modular approach significantly reduces the ongoing cost of glucose monitoring for patients. Uniscreen's mission is to expand its modular sensing technology platform to other chronic diseases including cancer and kidney failure. The company's products are clinically approved and recommended by clinicians. Founded by researchers from IIT Madras, Uniscreen aims to make continuous glucose monitoring accessible and affordable for every patient in need.